$CNAT Company News U.S. stocks move lower afte

$CNAT Company News

U.S. stocks move lower after mixed jobs report 42 min ago - Anora Mahmudova
Macy’s, Bed Bath & Beyond slump; Gilead gains 9:29 a.m. Today - Sue Chang
‘Ex-energy’ to be investor catch-phrase as earnings roll around again 9:14 a.m. Today - Barbara Kollmeyer
Bed Bath & Beyond shares sink as sales miss consensus 6:48 p.m. Jan. 8, 2015 - Wallace Witkowski
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois

Conatus off big premarket 8:46 a.m. Today - Seeking Alpha
St. Jude Medical Starts Enrolment for Ablation Catheter Trial - Analyst Blog 2:10 p.m. Jan. 8, 2015 - Zacks.com
Medtronic Initiates Study on Absorbable Antibacterial Envelope - Analyst Blog 1:50 p.m. Jan. 8, 2015 - Zacks.com
Galectin up on Phase 1 results in NASH 8:50 a.m. Jan. 7, 2015 - Seeking Alpha
Conatus Pharmaceuticals (CNAT) Shares March Higher, Can It Continue? - Tale of the Tape 8:47 a.m. Jan. 7, 2015 - Zacks.com
Is Conatus Poised For A Breakout? 2:42 p.m. Jan. 6, 2015 - Seeking Alpha
Medtronic's (MDT) IN.PACT Admiral DCB Wins FDA Go-Ahead - Analyst Blog 2:40 p.m. Jan. 6, 2015 - Zacks.com
Zimmer Holdings Scales 52-Week High on Portfolio Strength - Analyst Blog 1:55 p.m. Jan. 6, 2015 - Zacks.com
Stryker Acquires Assets of Canada-based CHG Hospital Beds - Analyst Blog 1:30 p.m. Jan. 6, 2015 - Zacks.com
Gilead Acquires Drug Program For Fatty Liver Disease 10:20 a.m. Jan. 6, 2015 - Investors Business Daily
IPO Stock Watch: FibroGen Up With Liver-Disease Field 3:40 p.m. Jan. 5, 2015 - Investors Business Daily
Conatus Pharmaceuticals Soars 40% Ahead Of Emricasan Results 9:07 a.m. Jan. 5, 2015 - benzinga.com
Conatus to report results from three clinical trials on Thursday 7:27 a.m. Jan. 5, 2015 - Seeking Alpha
The 2015 Calendar Of NASH Trial Catalysts Series Brings Huge Opportunities For Investors 3:29 a.m. Dec. 19, 2014 - Seeking Alpha
Conatus Pharmaceuticals: A Potential Double Worth Consideration 2:23 p.m. Dec. 13, 2014 - Seeking Alpha
European Ad Comm gives thumbs up to AbbVie's HCV combo 8:48 a.m. Nov. 21, 2014 - Seeking Alpha
2 Attractive But Speculative Biotech Gems For Consideration 9:17 a.m. Nov. 14, 2014 - Seeking Alpha
Conatus Pharmaceuticals' (CNAT) CEO Steven Mento on Q3 2014 Results - Earnings Call Transcript 8:05 p.m. Nov. 12, 2014 - Seeking Alpha
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog 1:50 p.m. Nov. 11, 2014 - Zacks.com
Gilead presents Harvoni data 11:03 a.m. Nov. 11, 2014 - Seeking Alpha


Conatus to Report Top-line Results From ACLF and Organ Impairment Clinical Trials of Emricasan 7:02 a.m. Jan. 5, 2015 - GlobeNewswire
Conatus Pharmaceuticals to Present at Two December Investor Conferences 7:02 a.m. Nov. 24, 2014 - GlobeNewswire
Conatus Pharmaceuticals Reports Third Quarter 2014 Financial Results and Program Updates 4:04 p.m. Nov. 12, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 7:02 a.m. Nov. 11, 2014 - GlobeNewswire
Conatus Pharmaceuticals Presents Late-Breaking Poster at AASLD Annual Meeting 8:01 a.m. Nov. 10, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Report Third Quarter 2014 Financial Results 4:01 p.m. Nov. 5, 2014 - GlobeNewswire
Conatus Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for AASLD Annual Meeting 9:01 a.m. Oct. 8, 2014 - GlobeNewswire
Conatus Pharmaceuticals Appoints David T. Hagerty as Executive Vice President, Clinical Development 3:02 p.m. Oct. 1, 2014 - GlobeNewswire
Conatus Pharmaceuticals Initiates Phase 2 Trial in Patients with Liver Cirrhosis and Separate Open Label Phase 2 Trial in Cirrhosis Patients with Portal Hypertension 6:02 a.m. Sept. 2, 2014 - GlobeNewswire
Conatus Pharmaceuticals Reports Second Quarter 2014 Financial Results and Program Updates 3:02 p.m. Aug. 13, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Report Second Quarter 2014 Financial Results 3:02 p.m. Aug. 6, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Relocate Corporate Headquarters 6:02 a.m. July 7, 2014 - GlobeNewswire
Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array 5:30 a.m. July 3, 2014 - PR Newswire - PRF
Conatus Pharmaceuticals to Present at Upcoming Investor Conferences 6:02 a.m. May 27, 2014 - GlobeNewswire
Conatus Pharmaceuticals Reports First Quarter 2014 Financial Results and Program Updates 3:02 p.m. May 13, 2014 - GlobeNewswire
Conatus Pharmaceuticals Initiates Phase 2b Trial Targeting Fibrosis in Liver Transplant Recipients 6:02 a.m. May 12, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Report First Quarter 2014 Financial Results 3:02 p.m. May 6, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Present at Deutsche Bank Health Care Conference 6:02 a.m. April 30, 2014 - GlobeNewswire
Conatus Pharmaceuticals Reports 2013 Financial Results and Program Updates 3:12 p.m. March 27, 2014 - GlobeNewswire
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2013 Financial Results 3:01 p.m. March 20, 2014 - GlobeNewswire